Mixed community-acquired lower respiratory tract infections

Current Infectious Disease Reports

Volumn 9, Issue 1, 2007, Pages 14-20

  Tarsia, Paolo ^b   Aliberti, Stefano ^b   Pappalettera, Maria ^b   Blasi, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AGE DISTRIBUTION; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; CHILDHOOD DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG CHOICE; DRUG TREATMENT FAILURE; ELDERLY CARE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MIXED INFECTION; MYCOPLASMA PNEUMONIAE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; STREPTOCOCCUS PNEUMONIAE; VIRUS IDENTIFICATION; VIRUS PNEUMONIA;

EID: 33847003363     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-007-0017-0     Document Type: Review

References (49)

1. Combes A, Figliolini C, Trouillet JL, et al.: Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002, 121:1618-1623.
2. Brogden KA, Guthmiller JM, Taylor CE: Human polymicrobial infections. Lancet 2005, 365:253-255.
3. Sethi S: Bacterial pneumonia: managing a deadly complication of influenza in older adults with comorbid disease. Geriatrics 2002, 57:56-61.
4. Beadling C, Slifka MK: How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis 2004, 17:185-191.
5. McCullers JA, Rehg JE: Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002, 186:341-350.
6. Okamoto S, Kawabata S, Nakagawa I, et al.: Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol 2003, 77:4104-4112.
7. Peltola VT, Murti KG, McCullers JA: Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005, 192:249-257.
8. Marrie TJ, Peeling RW, Reid T, et al.: Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003, 21:779-784.
9. Gleason PP: The emerging role of atypical pathogens in community-acquired pneumonia. Pharmacotherapy 2002, 22:2S-11S.
10. Esposito S, Bosis S, Cavagna R, et al.: Characteristics of Streptococcus pneumoniae and atypical bacteral infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002, 35:1345-1352.
11. Laundy M, Ajayi-Obe E, Hawrami K, et al.: Influenza A community-acquired pneumonia in East London infants and young children. Pediatr Infect Dis J 2003, 22(10 Suppl):S233-S237.
12. Juvén T, Mertsola J, Waris M, et al.: Clinical response to antibiotic therapy for community-acquired pneumonia. Eur J Pediatr 2004, 136:140-144.
13. Tsolia MN, Psarras S, Bossios A, et al.: Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004, 39:681-686.
14. Michelow IC, Olsen K, Lozano J, et al.: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707.
15. Korppi M, Heiskanen-Kosma T, Kleemola M: Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004, 9:109-114.
16. Tsai MH, Huang YC, Chen CJ, et al.: Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome. J Microbiol Immunol Infect 2005, 38:117-122.
17. Lagerström F, Bader M, Foldevi M, et al.: Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, Sweden. Clin Microbiol Infect 2003, 9:645-652.
18. Beovic B, Bonac B, Kee D, et al.: Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. Eur J Clin Microbiol Dis 2003, 22:584-591.
19. Marrie TJ, Poulin-Costello M, Beecroft MD, Herman-Gnjidic Z: Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir Med 2005, 99:60-65.
20. Van der Eerden MM, Vlaspolder F, de Graaff CS, et al.: Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005, 24:241-249.
21. Watthanathum A, Chaoprasong C, Nunthapisud P, et al.: Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest 2003, 123:1512-1519.
22. Lauderdale TL, Chang FY, Ben RJ, et al.: Etiology of community-acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005, 99:1079-1086.
23. Saito A, Kohno S, Matsushima T, et al.: Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother 2006, 12:63-69.
24. Huang HH, Zhang TT, Xiu QF, et al.: Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis 2006, 25:369-374.
25. Templeton KE, Schlatinga SA, van den Eeden WC, et al.: Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005, 41:345-351.
26. Gutiérrez F, Masiá M, Rodriguez JC: Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis 2005, 24:377-383.
27. de Roux A, Ewig S, Garcia E: Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006, 27:795-800.
28. Falguera M, Pifarre R, Martin A, et al.: Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005, 128:3233-3239.
29. Roson B, Carratalá J, Dorca J, et al.: Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001, 33:158-165.
30. Ruiz M, Ewig S, Marcos MA, et al.: Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160:397-405.
31. Wilson PA, Ferguson J: Severe community-acquired pneumonia: an Australian perspective. Intern Med J 2005, 35:699-705.
32. Yoshimoto A, Nakamura H, Fujimura M, Nakao S: Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality. Intern Med 2005, 44:710-716.
33. El-Solh AA, Pietrantoni C, Bhat A, et al.: Colonization of dental plaques: A reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 2004, 126:1575-1582.
34. El-Solh AA, Pietrantoni C, Bhat A, et al.: Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003, 167:1650-1654.
35. Reza Shariatzadeh M, Huang JQ, Marrie TJ: Differences in features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006, 54:296-302.
36. Fernandez-Sabé N, Carratala J, Roson B, et al.: Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003, 82:159-169.
37. Eller J, Ede A, Schaberg T, et al.: Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998, 113:1542-1548.
38. Soler N, Torres A, Ewig S, et al.: Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998, 157:1498-1505.
39. Rosell A, Monsó E, Soler N, et al.: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005, 165:891-897.
40. Seemungal T, Harper-Owen R, Bhowmik A, et al.: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1618-1623.
41. Rohde G, Wiethege A, Borg I, et al.: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 2003, 58:37-42.
42. Bandi V, Jakubowycz M, Kinyon C, et al.: Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 2003, 37:69-75.
43. Cameron RJ, de Wit D, Welsh TN, et al.: Virus infection in exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation. Intensive Care Med 2006, 32:1022-1029.
44. Wilkinson TM, Hurst JR, Perera WR, et al.: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006, 129:317-324.
45. Sethi S: Coinfection in exacerbations of COPD: a new frontier. Chest 2006, 129:223-224.
46. Papi A, Bellettato CM, Braccioni F, et al.: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114-1121.
47. Waterer GW: Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia. Curr Opin Infect Dis 2005, 18:157-163.
48. Treanor JJ, Hayden FG, Vrooman PS, et al.: Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000, 283:1016-1024.
49. Nordin J, Mullooly J, Poblete S, et al.: Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons aged 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001, 184:665-670.